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a b s t r a c t
We report a case of leiomyosarcoma of the inferior nasal turbinate. The patient, a 68-year-old Caucasian
male, presented with 4e6 weeks of epistaxis that was resistant to nasal packing and septal cautery. Upon
inspection in the operating room, a small mass was excised from the inferior turbinate. High-power
H&E-stained microscopy demonstrated bundles of malignant smooth muscle cells, and immunohisto-
chemical stains were strongly positive for desmin, smooth muscle actin and vimentin, while negative for
pankeratin EA1/EA3 and CaM 5.2, suggesting leiomyosarcoma as the diagnosis. Clear margins were
obtained at a second surgery. At the time of this writing it is 8 months since his last surgery and he has
remained symptom free.
© 2017 Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/
licenses/by/4.0/).
Introduction
Approximately 8.4% of all sarcomas are located in the head and
neck. Leiomyosarcoma (LMS) is a malignant tumor of smooth
muscle origin frequently found in the uterus and digestive tract. In
the head and neck, however, LMS makes up only 2.3% of non-
epithelial tumors of the paranasal sinuses, nasopharynx and nose
[1]. This is in part due to the small amounts of smoothmuscle in the
head and neck, largely limited to the tunica media of vasculature
[2]. Moreover, it has been shown that LMS isolated to the head and
neck are more aggressive and carry a poorer prognosis than
gastrointestinal variants. To our knowledge, less than 20 cases of
nasal leiomyosarcoma have been reported globally. Here we pre-
sent a case of this rare entity and discuss appropriate treatment.
Case presentation
The patient, a 68-year-old Caucasian male, was referred to our
clinic with recurrent intermittent epistaxis for 4e6 weeks. The
epistaxis was intermittently treated with nasal packing and septal
cautery but failed to resolve. He denied fatigue, anorexia or weight
loss and admitted to chronic rinosinusitis and nasal airway
obstruction for most of his adult life with a history of melanoma of
the face.
In-office nasal examination revealed a significant septal devia-
tion on the side of the recurrent epistaxis and inferior turbinate
hypertrophy. No masses or lesions were appreciated during office
endoscopy. The decision was made to proceed with nasal endos-
copy, septoplasty and submucosal reduction (SMR) of the inferior
turbinates to control epistaxis and improve his nasal obstruction.
While performing the SMRof the left inferior turbinate, an irregular
mass was encountered on the lateral undersurface of the turbinate,
abutting the medial wall of the maxillary sinus. This only became
visible after a reduction in the inferior turbinate had been per-
formed. Multiple biopsies of this area were sent as permanent
specimens for pathologic review. The remainder of the SMR, sep-
toplasty and endoscopy were unremarkable.
Histopathologic examination demonstrated submucosal
involvement by a high-grade sarcoma with areas of necrosis. High-
power H&E-stained microscopy demonstrated bundles of malig-
nant smooth muscle cells (Fig. 1). Immunohistochemical (IHC)
stains (Figs. 2 and 3) were strongly positive for desmin, smooth
muscle actin and vimentin while negative for pankeratin EA1/EA3
and CaM 5.2.
A diagnosis of grade 3 leiomyosarcoma of the left inferior nasal
turbinate was made. Subsequent PET and CT scans were negative
for distal and local malignancies.
Given the need to assess surgical margins, the patient was taken
back to the operating room for left inferior turbinectomy, maxillary
antrostomy/partial medial maxillectomy and anterior ethmoidec-
tomy. All margins were negative for residual leiomyosarcoma.* Corresponding author. Dartmouth-Hitchcock Medical Center, One Medical
Center Drive, Lebanon, NH 03766, United States.
E-mail address: Christopher.w.harper@hitchcock.org (C.W. Harper).
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His case was presented at our multidisciplinary tumor confer-
ence and the decision was made to withhold adjuvant therapy. The
patient has been compliant with close follow-up and has had no
signs of recurrence as of 8 months after his second operation.
Discussion
Dobben et al. reported the first case of LMS arising from the
nasopharynx in 1958, and since that time fewer than 20 cases have
been reported worldwide [3].
Across reports thus far, the mean age of onset is 53, with a slight
male predominance of 1.1:1. Similar to other sinonasal malig-
nancies, the most common presenting symptoms are congestion,
epistaxis, pain, local swelling, and rhinorrhea [4].
The rarity at which LMS presents in the sinonasal cavity is likely
attributed to the paucity of smooth muscle in this region. Some
suggest that the cells of origin are found in the tunica media of
blood vessel walls, while others have suggested the tumor arises
from undifferentiated mesenchymal tissue or even myoepithelial
cells in submucosal glands [2].
H&E staining of LMS shows intersecting fascicles of malignant
spindle cells with cigar-shaped or atypically lobulated nuclei;
however, LMS can be difficult to distinguish from other soft tissue
sarcomas by light microscopy alone. Differential diagnoses include
fibrosarcoma, rhabdomyosarcoma, malignant schwannoma and
benign spindle-cell tumors. To differentiate between these various
tumors, IHC staining methods are often necessary. As was used in
our case, IHC staining with antibodies to smooth muscle actin and
desmin as well as vimentin as a marker for mesenchymal tissue are
useful in demonstrating LMS as the diagnosis.
Wide surgical excision is the treatment of choice for nasal LMS.
As LMS in the sinonasal tract has not been shown to be radiosen-
sitive, radiation therapy of primary, recurrent or metastatic LMS is
generally ineffective in reducing tumor size. Chemotherapy for
sinonasal leiomyosarcoma has only been used effectively in adju-
vant with surgery and may be considered in patients with multiple
metastases and/or a large primary tumor [5]. There is a lack of
literature regarding management of the neck in patients presenting
with nasal LMS; however, as spread tends to be loco regional, there
is likely limited benefit from neck dissection or radiation to the
neck.
Conclusion
Sinonasal leiomyosarcoma is a rare entity. When encountered,
surgical excision should be considered the primary treatment
modality, with reservation of chemotherapy for advanced disease.
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Fig. 1. High-powered (40X) H&E-stained micrograph showing fascicles of malignant
spindle cells with cigar-shaped nuclei.
Fig. 2. Positive desmin immunohistochemical stain (10X).
Fig. 3. Positive smooth muscle actin immunohistochemical stain (10X).
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